Skip to main content
. 2013 Apr 24;2(2):e000104. doi: 10.1161/JAHA.112.000104

Figure 2.

Figure 2.

Kaplan–Meier analysis of major adverse cardiac events in patients with chronic kidney disease. Patients stratified according to optimal cutoff for serum arylesterase and paraoxonase activity levels as follows: “high” paraoxonase [≥280 nmol(L·min) per mL] or “low” paraoxonase [<280 nmol(L·min) per mL] and “high” arylesterase [≥70 μmol(L·min) per mL] or “low” arylesterase [<70 μmol(L·min) per mL].MI indicates myocardial infarction.